Back to top
more

Zoetis (ZTS)

(Real Time Quote from BATS)

$173.01 USD

173.01
1,412,360

+2.64 (1.55%)

Updated Nov 7, 2024 12:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zoetis (ZTS) Matches Q4 Earnings Estimates

by Zacks Equity Research

Zoetis (ZTS) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

COLL or ZTS: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

COLL vs. ZTS: Which Stock Is the Better Value Option?

Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Higher sales of Zoetis' (ZTS) key drugs like Apoquel, Cytopoint, Simparica Trio, Librela and Solensia are expected to have driven sales, partially offset by lower sales of livestock, cattle, poultry and swine products.

Zoetis (ZTS) Stock Moves -0.78%: What You Should Know

by Zacks Equity Research

Zoetis (ZTS) closed the most recent trading day at $160.81, moving -0.78% from the previous trading session.

Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Zoetis (ZTS) closed at $171 in the latest trading session, marking a +1.9% move from the prior day.

Zoetis (ZTS) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Zoetis (ZTS) closed at $165.18 in the latest trading session, marking a -1.82% move from the prior day.

UTHR vs. ZTS: Which Stock Is the Better Value Option?

by Zacks Equity Research

UTHR vs. ZTS: Which Stock Is the Better Value Option?

COLL vs. ZTS: Which Stock Is the Better Value Option?

by Zacks Equity Research

COLL vs. ZTS: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Top Research Reports for Berkshire Hathaway, Walmart, and P&G

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Walmart Inc. (WMT) and The Procter & Gamble Company (PG).

ASRT vs. ZTS: Which Stock Is the Better Value Option?

by Zacks Equity Research

ASRT vs. ZTS: Which Stock Is the Better Value Option?

ASRT or ZTS: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ASRT vs. ZTS: Which Stock Is the Better Value Option?

Why Is Ionis Pharmaceuticals (IONS) Down 16.4% Since Last Earnings Report?

by Zacks Equity Research

Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Zacks Analyst Blog Highlights Procter & Gamble, Coca-Cola, The Progressive, Zoetis and Palo Alto Networks

by Zacks Equity Research

Procter & Gamble, Coca-Cola, The Progressive, Zoetis and Palo Alto Networks are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Procter & Gamble, Coca-Cola & Progressive

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), The Coca-Cola Company (KO) and The Progressive (PGR).

ASRT vs. ZTS: Which Stock Is the Better Value Option?

by Zacks Equity Research

ASRT vs. ZTS: Which Stock Is the Better Value Option?

ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

ASRT vs. ZTS: Which Stock Is the Better Value Option?

Zoetis' (ZTS) Lags Q3 Earnings Estimates, Lowers 2022 Guidance

by Zacks Equity Research

Zoetis' (ZTS) earnings miss estimates in third-quarter 2022. Revenues, though up, also miss estimates due to the supply constraints in the international market. Zoetis lowers its financial guidance.

Zoetis (ZTS) Q3 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Zoetis (ZTS) delivered earnings and revenue surprises of -2.42% and 3.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Kinjel Shah headshot

Drug, Biotech Stocks' Q3 Earnings on Nov 3: AMGN, REGN & More

by Kinjel Shah

Let us look at five drug and biotech companies, AMGN, REGN, ZTS, and MRNA, which are gearing up for their earnings release.

Why Zoetis (ZTS) Might Surprise This Earnings Season

by Zacks Equity Research

Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zoetis (ZTS) to Report Q3 Earnings: Is a Beat in Store?

by Zacks Equity Research

Zoetis (ZTS) is anticipated to report positive earnings and revenues for third-quarter 2022. It will also provide an update on its pipeline on the earnings call.

Cronos Group (CRON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zoetis (ZTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

by Zacks Equity Research

Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JAZZ or ZTS: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

JAZZ vs. ZTS: Which Stock Is the Better Value Option?